These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2568404)

  • 21. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
    Mokler DJ; Robinson SE; Rosecrans JA
    Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphetamine, two metabolites of 3,4-methylenedioxymethamphetamine, on central serotonergic and dopaminergic systems.
    Johnson M; Elayan I; Hanson GR; Foltz RL; Gibb JW; Lim HK
    J Pharmacol Exp Ther; 1992 May; 261(2):447-53. PubMed ID: 1349640
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The action of (+/-)-MDMA on medial prefrontal cortical neurons is mediated through the serotonergic system.
    Pan HS; Wang RY
    Brain Res; 1991 Mar; 543(1):56-60. PubMed ID: 1675924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of N-ethyl-3,4-methylenedioxyamphetamine (MDE) on central serotonergic and dopaminergic systems of the rat.
    Johnson M; Hanson GR; Gibb JW
    Biochem Pharmacol; 1987 Dec; 36(23):4085-93. PubMed ID: 2446629
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats.
    Schmidt CJ; Abbate GM; Black CK; Taylor VL
    J Pharmacol Exp Ther; 1990 Nov; 255(2):478-83. PubMed ID: 1978728
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 3,4-Methylenedioxymethamphetamine-induced release of serotonin and inhibition of dorsal raphe cell firing: potentiation by L-tryptophan.
    Sprouse JS; Bradberry CW; Roth RH; Aghajanian GK
    Eur J Pharmacol; 1990 Mar; 178(3):313-20. PubMed ID: 1971220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature.
    O'Shea E; Orio L; Escobedo I; Sanchez V; Camarero J; Green AR; Colado MI
    Br J Pharmacol; 2006 Jul; 148(6):778-85. PubMed ID: 16770327
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") in the rat frontal cortex but not in the hippocampus.
    García-Osta A; Del Río J; Frechilla D
    Brain Res Mol Brain Res; 2004 Jul; 126(2):181-7. PubMed ID: 15249142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of 3,4-methylenedioxymethamphetamine on 3,4-dihydroxyphenylalanine accumulation in the striatum and nucleus accumbens.
    Nash JF; Meltzer HY; Gudelsky GA
    J Neurochem; 1990 Mar; 54(3):1062-7. PubMed ID: 1689375
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of cortical tryptophan hydroxylase by acute morphine treatment: blockade by 6-hydroxydopamine.
    Boadle-Biber MC; Johannessen JN; Narasimhachari N; Phan TH
    Eur J Pharmacol; 1987 Jul; 139(2):193-204. PubMed ID: 2443368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.
    Colado MI; Williams JL; Green AR
    Br J Pharmacol; 1995 Aug; 115(7):1281-9. PubMed ID: 7582557
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tryptophan hydroxylase. The role of oxygen, iron, and sulfhydryl groups as determinants of stability and catalytic activity.
    Kuhn DM; Ruskin B; Lovenberg W
    J Biol Chem; 1980 May; 255(9):4137-43. PubMed ID: 7372670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective reduction of striatal type II glucocorticoid receptors in rats by 3,4-methylenedioxymethamphetamine (MDMA).
    Lowy MT; Nash JF; Meltzer HY
    Eur J Pharmacol; 1989 Apr; 163(1):157-61. PubMed ID: 2472965
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevation of serum prolactin and corticosterone concentrations in the rat after the administration of 3,4-methylenedioxymethamphetamine.
    Nash JF; Meltzer HY; Gudelsky GA
    J Pharmacol Exp Ther; 1988 Jun; 245(3):873-9. PubMed ID: 2898523
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term alteration in the central monoaminergic systems of the rat by 2,4,5-trihydroxyamphetamine but not by 2-hydroxy-4,5-methylenedioxymethamphetamine or 2-hydroxy-4,5-methylenedioxyamphetamine.
    Elayan I; Gibb JW; Hanson GR; Foltz RL; Lim HK; Johnson M
    Eur J Pharmacol; 1992 Oct; 221(2-3):281-8. PubMed ID: 1358654
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonergic modulation of rat pup ultrasonic vocal development: studies with 3,4-methylenedioxymethamphetamine.
    Winslow JT; Insel TR
    J Pharmacol Exp Ther; 1990 Jul; 254(1):212-20. PubMed ID: 1973197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of acute N-ethyl-3,4-methylenedioxyamphetamine (MDE) action on the central serotonergic system.
    Johnson M; Hanson GR; Gibb JW
    Biochem Pharmacol; 1989 Dec; 38(23):4333-8. PubMed ID: 2480796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDMA as a discriminative stimulus: isomeric comparisons.
    Schechter MD
    Pharmacol Biochem Behav; 1987 May; 27(1):41-4. PubMed ID: 2886996
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine.
    Schmidt CJ
    J Pharmacol Exp Ther; 1987 Jan; 240(1):1-7. PubMed ID: 2433425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serotonin release contributes to the locomotor stimulant effects of 3,4-methylenedioxymethamphetamine in rats.
    Callaway CW; Wing LL; Geyer MA
    J Pharmacol Exp Ther; 1990 Aug; 254(2):456-64. PubMed ID: 1974635
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.